Literature DB >> 28028756

Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.

S Hessam1, M Sand1, M Skrygan1, T Gambichler1, F G Bechara2.   

Abstract

Hidradenitis suppurativa (HS) has been associated with marked inflammatory perturbation. The mechanisms regulating the inflammatory network remain elusive. microRNAs (miRNAs) have been described as gene regulators of inflammation. We evaluated the messenger RNA (mRNA) expression levels of six selected inflammation-related miRNAs in lesional and perilesional skin samples of HS patients and in healthy controls. Samples of 15 HS patients and 10 healthy controls were included in this prospective study. Expression levels of the miRNAs miRNA-155-5p, miRNA-223-5p, miRNA-31-5p, miRNA-21-5p, miRNA-125b-5p, and miRNA-146a-5p were studied by quantitative real-time reverse transcription polymerase chain reaction. We observed a significant overexpression of miRNA-155-5p, miRNA-223-5p, miRNA-31-5p, miRNA-21-5p, and miRNA-146a-5p in lesional HS skin compared to healthy controls. Expression of these miRNAs was also significantly increased in lesional HS skin when compared to perilesional skin. Only miRNA-155-5p showed an increased expression in perilesional skin compared to healthy controls. In contrast, miRNA-125b-5p had a significantly lower expression in lesional HS skin compared to perilesional skin. We found that the studied inflammation-related miRNAs were significantly dysregulated in lesional HS skin and may have regulatory roles in the inflammatory process of HS. Given their predicted targets and functions, our findings point to these miRNAs as potential disease biomarkers, and manipulation might be used therapeutically to target the inflammatory pathway in HS.

Entities:  

Keywords:  hidradenitis suppurativa; inflammation-related microRNAs; inflammatory skin disease; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28028756     DOI: 10.1007/s10753-016-0492-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  44 in total

1.  Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa Lesions.

Authors:  Schapoor Hessam; Michael Sand; Dimitrios Georgas; Agnes Anders; Falk G Bechara
Journal:  Skin Pharmacol Physiol       Date:  2016-06-29       Impact factor: 3.479

2.  Identification of reference miRNAs in human tumors by TCGA miRNA-seq data.

Authors:  Cheng Zhan; Li Yan; Lin Wang; Wei Jiang; Yongxing Zhang; Junjie Xi; Li Chen; Yulin Jin; Yulei Qiao; Yu Shi; Qun Wang
Journal:  Biochem Biophys Res Commun       Date:  2014-09-27       Impact factor: 3.575

Review 3.  [Hidradenitis suppurativa/acne inversa: An update].

Authors:  J Kirschke; S Hessam; F G Bechara
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

5.  MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40.

Authors:  Ning Xu; Florian Meisgen; Lynn M Butler; Gangwen Han; Xiao-Jing Wang; Cecilia Söderberg-Nauclér; Mona Ståhle; Andor Pivarcsi; Enikö Sonkoly
Journal:  J Immunol       Date:  2012-12-10       Impact factor: 5.422

6.  Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.

Authors:  V U Emelianov; F G Bechara; R Gläser; E A Langan; W M Taungjaruwinai; J M Schröder; K C Meyer; R Paus
Journal:  Br J Dermatol       Date:  2012-04-04       Impact factor: 9.302

Review 7.  MicroRNA in non-melanoma skin cancer.

Authors:  Michael Sand; Daniel Sand; Peter Altmeyer; Falk G Bechara
Journal:  Cancer Biomark       Date:  2012       Impact factor: 4.388

8.  Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy.

Authors:  A Pivarcsi; F Meisgen; N Xu; M Ståhle; E Sonkoly
Journal:  Br J Dermatol       Date:  2013-09       Impact factor: 9.302

9.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.

Authors:  Heidi J Peltier; Gary J Latham
Journal:  RNA       Date:  2008-03-28       Impact factor: 4.942

10.  Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

Authors:  Alexa B Kimball; Martin M Okun; David A Williams; Alice B Gottlieb; Kim A Papp; Christos C Zouboulis; April W Armstrong; Francisco Kerdel; Michael H Gold; Seth B Forman; Neil J Korman; Evangelos J Giamarellos-Bourboulis; Jeffrey J Crowley; Charles Lynde; Ziad Reguiai; Errol-Prospero Prens; Eihab Alwawi; Nael M Mostafa; Brett Pinsky; Murali Sundaram; Yihua Gu; Dawn M Carlson; Gregor B E Jemec
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245

View more
  11 in total

1.  Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.

Authors:  Claudia J Posso-De Los Rios; Akua Sarfo; Mondana Ghias; Raed Alhusayen; Iltefat Hamzavi; Michelle A Lowes; Afsaneh Alavi
Journal:  Exp Dermatol       Date:  2019-04-29       Impact factor: 3.960

Review 2.  MiR-146a/b: a family with shared seeds and different roots.

Authors:  Mark R Paterson; Alison J Kriegel
Journal:  Physiol Genomics       Date:  2017-02-17       Impact factor: 3.107

3.  Shanzhiside methylester protects against depression by inhibiting inflammation via the miRNA-155-5p/SOCS1 axis.

Authors:  Zhongwen Sun; Honggang Zhan; Cheng Wang; Ping Guo
Journal:  Psychopharmacology (Berl)       Date:  2022-03-16       Impact factor: 4.530

4.  LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.

Authors:  Yun Liu; Lei Li; Jia-Yao Wang; Fei Gao; Xia Lin; Shi-Shuai Lin; Zhi-Yang Qiu; Zun-Hong Liang
Journal:  Mol Cell Biochem       Date:  2022-08-29       Impact factor: 3.842

5.  Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.

Authors:  Samuel Der Sarkissian; Schapoor Hessam; Joslyn S Kirby; Michelle A Lowes; Dillon Mintoff; Haley B Naik; Hans Christian Ring; Nisha Suyien Chandran; John W Frew
Journal:  JAMA Dermatol       Date:  2022-03-01       Impact factor: 11.816

Review 6.  Hidradenitis suppurativa: an update on connecting the tracts.

Authors:  Mallory K Smith; Cynthia L Nicholson; Angela Parks-Miller; Iltefat H Hamzavi
Journal:  F1000Res       Date:  2017-07-28

Review 7.  An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis.

Authors:  Paola M Tricarico; Michele Boniotto; Giovanni Genovese; Christos C Zouboulis; Angelo V Marzano; Sergio Crovella
Journal:  Front Immunol       Date:  2019-04-25       Impact factor: 7.561

8.  Circulating microRNAs in Hidradenitis Suppurativa.

Authors:  Bruna De Felice; Concetta Montanino; Marta Mallardo; Graziella Babino; Edi Mattera; Giovanni Ragozzino; Giuseppe Argenziano; Aurora Daniele; Ersilia Nigro
Journal:  Genes (Basel)       Date:  2022-08-26       Impact factor: 4.141

9.  Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds.

Authors:  Sun Young Wang; Hyosuk Kim; Gijung Kwak; Sung Duk Jo; Daeho Cho; Yoosoo Yang; Ick Chan Kwon; Ji Hoon Jeong; Sun Hwa Kim
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

Review 10.  MicroRNA Cross-Involvement in Acne Vulgaris and Hidradenitis Suppurativa: A Literature Review.

Authors:  Francesco Borgia; Lucia Peterle; Paolo Custurone; Mario Vaccaro; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.